Elanco Animal Health develops and markets medicines, vaccines and other health products for companion animals and livestock. Its portfolio covers parasiticide, anti-infective and other therapeutic categories sold to veterinarians, producers and pet owners. The company focuses on animal health as a pure-play business spanning farm productivity and pet care.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 1,241 | — | 11 | — |
| Q3 2025 | 1,137 | — | -34 | — |
| Q4 2025 | 1,144 | — | -276 | — |
| Q1 2026 | 1,371 | — | 57 | — |
| Q2 2026 | 1,368 | 10.2% | 54 | 390.9% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Watsco, Inc. (WSO B), Madison Air Solutions Corporation (MAIR), Frontline plc (FRO), Moog Inc. (MOG A), Deckers Outdoor Corporation (DECK), On Holding AG (ONON)